Rapid Molecular Diagnostics in Vulvovaginal Candidosis

Area of Science:

• Medical Diagnostics
• Mycology
• Molecular Biology

Background:

• Vulvovaginal candidosis (VVC) affects many women, with current diagnostics facing limitations.
• Traditional VVC diagnosis relies on clinical evaluation and lab tests, often causing delays and incorrect treatment.
• There's a need for improved diagnostic accuracy and efficiency in VVC management.

Purpose of the Study:

• To review the effectiveness of molecular diagnostic tools for VVC.
• To offer guidance on implementing these molecular diagnostics in clinical settings.
• To compare molecular methods with conventional VVC diagnostic approaches.

Main Methods:

• A PubMed literature search identified studies on rapid diagnostic tests for vulvovaginal Candida.
• Inclusion criteria focused on molecular diagnostics for Candida species detection in VVC.
• Excluded studies on non-vaginal infections, non-English articles, and animal/in vitro research.

Main Results:

• Twenty-three studies were included, focusing on nucleic acid amplification tests/polymerase chain reaction (NAAT/PCR) and DNA probes.
• NAAT/PCR assays showed high sensitivity and specificity (>86%) for VVC diagnosis, surpassing conventional methods.
• DNA probes had lower sensitivity, and emerging technologies like AI show future promise.

Conclusions:

• Molecular diagnostics represent a major advancement in managing VVC.
• Traditional diagnostic methods retain value in resource-limited environments.
• Improved diagnostic precision is achievable with newer technologies.